<DOC>
	<DOC>NCT00895726</DOC>
	<brief_summary>Primary Objective: To assess the efficacy of APD209 in adult patients with active cachexia associated with advanced malignancy and not caused by simple starvation. Secondary Objective: To assess the safety of APD209 in patients with advanced malignancy and active cachexia.</brief_summary>
	<brief_title>Pilot Study of APD209 in Cancer Cachexia</brief_title>
	<detailed_description />
	<mesh_term>Cachexia</mesh_term>
	<criteria>Involuntary loss of weight of &gt;= 2% in 2 months or &gt;= 5% in 6 months, and ongoing in recent weeks, without (or with successfully treated) secondary causes of impaired oral nutritional intake (simple starvation).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>cachexia</keyword>
	<keyword>neoplasms</keyword>
</DOC>